4).8 Adolescent patients In the ALLEGRO-2b/3 trial, 15% of the population consisted of hard-to-treat adolescents with SALT 50% (severe AA), a mean disease duration of 6.5 years, and 40% with AT or AU.8 Although limited by small sample size, the results were consistent with those in the overall study population
Desmots F, Rissel M, Gilot D et al (2002) Pro-inflammatory cytokines tumor necrosis factor and interleukin-6 and survival factor epidermal growth factor positively regulate the murine GSTA4 enzyme in hepatocytes
Defined BSA concentration is preferred over variable serum albumin in standard culture media for quantitative dose-response work
It is a triple agonist of the GLP-1, GIP, and glucagon receptors
Do not crush, cut, chew, or dissolve the pill If you miss a dose, skip that days dose and get back on track by taking the scheduled dose the next day Source: Wegovy.com Questions about whether this medication is right for you